Alleviation of Anemia by SGLT2 Inhibitors in Patients with CKD: Mechanisms and Results of Long-Term Placebo-Controlled Trials

Clin J Am Soc Nephrol. 2023 Oct 30. doi: 10.2215/CJN.0000000000000362. Online ahead of print.NO ABSTRACTPMID:37902773 | DOI:10.2215/CJN.0000000000000362

Source: Clinical Journal of the American Society of Nephrology : CJASN - October 30, 2023 Category: Urology & Nephrology Authors: Milton Packer Source Type: research